Gaugler Daryl's Form 4 filing
Pacira BioSciences, Inc. (PCRX) · filed Jun 13, 2024
- Accession no.
- 0001396814-24-000078
- Filed
- Jun 13, 2024
- Trade date
- Jun 12-13, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions. Open-market sales total $28.4K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gaugler DarylCIK 0001928278 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 12, 2024 | Common Stock | AGrant or awardAcquired | +54,300 | $0.00 | $0 | 117,039.58 | Direct | |
| Jun 13, 2024 | Common Stock | SSaleDisposed | −1,000 | $28.38 | −$28,380 | 116,039.58 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.